USPTO serial 98558948
GREEN GENES
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- TAYLOR, SLOAN H
- Law office
- TMO LAW OFFICE 129
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GREEN GENES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SAFFRON WALDEN, Essex, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey H. Greene
Jeffrey H. Greene Foley & Lardner LLP90 Park AvenueNew York, NY 10016-1314United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the biochemical and chemical industry; Chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Active chemical ingredients for use in the production of drugs, pharmaceuticals and antibodies; DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for scientific and research use; Nucleic acids comprising synthetic nucleotides for scientific and research use; Synthetic DNA nucleotides, synthetic RNA nucleotides, synthetic genes being biotechnologically formed genes, synthetic oligonucleotides and synthetic proteins for laboratory, scientific and industrial use; Chemical preparations, namely, synthetic enzymes, gene editing enzymes, DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for laboratory, scientific and industrial purposes; Synthetic DNA and RNA nucleotides for scientific and medical research; Synthetic DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for use in medical biologics and therapeutics; molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, XNA, oligonucleotides, genes and proteins | ACTIVE | — |
| 042 | Consultancy in relation to biochemistry and biotechnology; Research and development in the field of biotechnology and synthetic biology; Biological analysis; Biotechnological research relating to enzymatic synthesis; Provision of gene synthesis solutions, namely, creating and modifying genetic sequences for scientific purposes; Development and test of enzyme production methods; Evaluations, estimates, research and preparing related reports and technical documentation of genetic materials all in the field of enzymatic production; Scientific and technological services in the field of biotechnology consisting of the development of innovative processes to produce synthetic genes; Genetic engineering, namely, production of nucleic acid sequences; Research and development services relating to the creation of synthetic nucleic acid sequences; Genetic engineering services being the design, development, and testing of synthetic gene sequences; Design, development, rental and leasing of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids and genetic materials; Genetic engineering services, namely, manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; Genetic engineering and scientific laboratory services being the design, development and testing of synthetic gene sequences in complex gene production; Research and development services in the field of nucleic acid synthesis technology; Technical consulting in the field of biotechnology; Genetic engineering, namely, production of complex gene sequences; Consultancy, advisory and information services related to the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 11, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 10, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 10, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 10, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 6, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 6, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 6, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 25, 2024 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 25, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 20, 2024 | NWAP | NEW APPLICATION ENTERED | — |